4 ms·
The argument: In large part because natural immunity from prior infection is far more common than can be measured by testing. Testing has been capturing only fr
by Animats 6y ago
The argument: In large part because natural immunity from prior infection is far more common than can be measured by testing. Testing has been capturing only from 10% to 25% of infections, depending on when during the pandemic someone got the virus. Applying a time-weighted case capture average of 1 in 6.5 to the cumulative 28 million confirmed cases would mean about 55% of Americans have natural immunity.
That's far higher than what the CDC measures. They have actual data on whether people show antibodies.[1] Their main data source is from random blood samples processed by commercial labs where the samples were taken for some other purpose. The trouble is, the blood lab data runs way behind; the latest data is about 60 days old. But that's what to watch. It's annoying that so little current data is available on this. Anyway, as of late December, those numbers are from 3% (Hawaii) to 23% (North Dakota).
Blood samples are also taken from blood donations. If you donate blood, you get an COVID-19 antibody test done on it, and the Red Cross will tell you the results. (Yes, there's an app for that.) Those provide a crosscheck. People who have blood drawn for medical purposes tend to be sicker than average, and blood donors tend to be less sick than average. So one would expect the value for a whole population to be somewhere above the blood donor rate and below the medical sample rate.
Kansas is seeing 22% of blood donors showing antibodies, as of mid-January. Note that this includes people who have been vaccinated, which, for Kansas, is about 8%. That compares to 12% showing antibodies in lab samples as of mid-December, which was pre-vaccine. I haven't been able to find data from other states. Anyone finding that?
There are a number of approved blood-based antibody tests, and they have sensitivity levels from 89% to 99%. So test error isn't a big contributor to error.
So, while the measured values are moving up, nothing as high as 55% is showing up in the actual data yet. More current data would be a big help. Perhaps the data collection and publication will be improved under the new administration. Anyway, looking at the actuals is more useful than trying to project this from a measurement of something else.
[1] https://covid.cdc.gov/covid-data-tracker/?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fcases-updates%2Fcommercial-labs-interactive-serology-dashboard.html#national-lab https://covid.cdc.gov/covid-data-tracker/?CDC_AA_refVal=http...
[2] https://www.ctnewsonline.com/news/article_a97ef828-6122-11eb-abee-6f738d60f0f6.html https://www.ctnewsonline.com/news/article_a97ef828-6122-11eb...
- saalweachter 6y agoHe also uses a fairly low estimate of IFR: > Covid-19 deaths in the U.S. would also suggest much broader immunity than recognized. About 1 in 600 Americans has died of Covid-19, which translates to a population fatality rate of about 0.15%. The Covid-19 infection fatality rate is about 0.23%. These numbers indicate that roughly two-thirds of the U.S. population has had the infection. I usually see numbers like 0.5-0.6% bandied around for the US, which changes the deaths-IFR estimate to 1/4-1/3 of the country having been infected, rather than 2/3.
- addicted 6y agoEven if he is correct about the IFR the conclusion he draws is completely wrong. The 0.23 IFR would only be the current IFR. In the real world, the vast majority of the 0.15 % of the population died when the IFR was significantly higher, either due to the initial lack of understanding about the virus such as during the beginning of the pandemic, or due to the fact that even after we had a better understanding the majority of deaths across the country happened under situations where the IFR was higher due to hospitals being overloaded.
- saalweachter 6y agoAlso, even if we assume the good doctor is correct about the IFR, any time you try to posit the infection is much more wide-spread than experts believe, to get a lower iFR, you're also implicitly saying that you think the disease is much more virulent, which means the "herd immunity" thresholds are higher.
- akvadrako 6y agoWhy are you talking about antibodies? The author was specifically talking about T-cells which are more prevalent.